Erratum to: Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD

Author： Khdour Maher  

Publisher： Springer Publishing Company

ISSN： 2210-7703

Source： International Journal of Clinical Pharmacy, Vol.34, Iss.1, 2012-02, pp. : 142-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COPD self-management cost saving versus usual care

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 523, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Lifetime Cost-Utility Analysis of Patients with Refractory Epilepsy Treated with Adjunctive Topiramate Therapy: Cost-Effectiveness in Refractory Epilepsy

By Maltoni S.   Messori A.  

Clinical Drug Investigation, Vol. 23, Iss. 4, 2003-01 ,pp. : 225-232

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study

By Knapp Martin   Windmeijer Frank  

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 341-358

Adis International

Access to resources Recommend Favorite

Extended Dalteparin Prophylaxis for Venous Thromboembolic Events: Cost-Utility Analysis in Patients Undergoing Major Orthopedic Surgery

By Dranitsaris George  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 45-58

Adis International

Access to resources Recommend Favorite

Cost-benefit or cost-utility analysis?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite